Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

计划入组 49,065 人 · 首次发布于 2025 年 10 月 2 日

Suppression of Upper Lip Hair Growth Using Novel Hemp Extract

计划入组 25 人 · 首次发布于 2023 年 8 月 21 日

PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

计划入组 21 人 · 首次发布于 2023 年 4 月 10 日

Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center)

Kazakhstan Registers Promomed's Tirzetta as First Officially Available Tirzepatide Drug in the Country